Bottom line for companies like Paige, Artera, and PathAI (or hospitals using them):
- If you are offering clinical results on NY specimens, you must operate under a NYS clinical laboratory permit in the relevant categories. wadsworth.org
- Digital pathology/AI use itself does not trigger an LDT submission to CLEP, but you still need proper WSI validation, licensed pathologist sign-out, and you should ensure any AI/viewing software has the needed FDA status for its intended diagnostic use. wadsworth.org+1
https://www.wadsworth.org/regulatory/clep/clinical-labs/obtain-permit/test-approval
CLEP has determined that the use of digital imaging of slides in pathology will not be subject to submission requirements as a laboratory-developed test. This includes digital imaging of slides with subsequent use of artificial intelligence/machine learning.
As required in CLEP’s Clinical Laboratory Standards, a licensed pathologist must examine and report out all histopathology cases and all non-gynecologic cytopathology cases; a licensed pathologist must examine and report out all gynecological cases with epithelial cell abnormalities.
These standards also apply to any digital pathology using artificial intelligence/machine learning. Digital imagining systems and algorithms used in pathology may require approval from the Food and Drug Administration.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.